Weight loss pill shows promise in chinese adults: phase 3 trial complete
NCT ID NCT05890976
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a daily semaglutide tablet helps Chinese adults with overweight or obesity lose weight. About 200 participants took either the drug or a placebo for 44 weeks, along with guidance on diet and exercise. The main goals were to measure the percentage of weight lost and how many people lost at least 5% of their body weight.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Friendship Hospital, Capital Medical University-Endocrinology
Beijing, Beijing Municipality, 100050, China
-
Changzhou No.2 People's Hospital
Changzhou, Jiangsu, 213003, China
-
Chongqing University Three Gorges Hospital
Chongqing, Chongqing Municipality, 404000, China
-
General Hospital of Tianjin Medical University-Endocrinology
Tianjin, Tianjin Municipality, 300052, China
-
Huaihe Hospital of Henan University-Endocrinology
Kaifeng, Henan, 475000, China
-
Huashan Hospital Fudan University-Endocrinology
Shanghai, Shanghai Municipality, 200040, China
-
Huizhou Central People's Hospital-Endocrinology
Huizhou, Guangdong, 516001, China
-
Jinan Central Hospital
Ji'nan, Shandong, 250013, China
-
Jinan Central Hospital
Jinan, Shandong, 250013, China
-
Peking University People's Hospital-Endocrinology
Beijing, Beijing Municipality, 100044, China
-
Shanghai Pudong New Area People's Hospital-Endocrinology
Shanghai, Shanghai Municipality, 201200, China
-
Taihe Hospital-Endocrinology
Shiyan, Hubei, 442008, China
-
The Affiliated Hospital of Jiangsu University
Zhenjiang, Jiangsu, 212001, China
-
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, 450062, China
-
The First People's Hospital of Changde City-Endocrinology
Changde, Hunan, 415003, China
-
The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, 210011, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?